|
CXORF38 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.997010E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.942100E-02 |
| Normal-vs-Stage2 |
4.108200E-01 |
| Normal-vs-Stage3 |
7.242800E-01 |
| Normal-vs-Stage4 |
6.728600E-01 |
| Stage1-vs-Stage2 |
4.469800E-01 |
| Stage1-vs-Stage3 |
1.038560E-01 |
| Stage1-vs-Stage4 |
1.322760E-01 |
| Stage2-vs-Stage3 |
6.251000E-01 |
| Stage2-vs-Stage4 |
6.647600E-01 |
| Stage3-vs-Stage4 |
9.449800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.622650E-01 |
| Normal-vs-AfricanAmerican |
3.334200E-01 |
| Normal-vs-Asian |
6.002300E-03 |
| Caucasian-vs-AfricanAmerican |
1.787700E-02 |
| Caucasian-vs-Asian |
2.509600E-02 |
| AfricanAmerican-vs-Asian |
9.392900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.289000E-01 |
| Normal-vs-Female |
9.502800E-03 |
| Male-vs-Female |
3.606300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.804800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.431800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.728770E-01 |
| Normal-vs-Age(81-100Yrs) |
2.891200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.924600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.424400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.012600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.484600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.526600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.566400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.470580E-01 |
| Normal-vs-Grade 2 |
4.447500E-02 |
| Normal-vs-Grade 3 |
2.896800E-01 |
| Normal-vs-Grade 4 |
4.558200E-01 |
| Grade 1-vs-Grade 2 |
6.492800E-01 |
| Grade 1-vs-Grade 3 |
3.862600E-01 |
| Grade 1-vs-Grade 4 |
7.180000E-02 |
| Grade 2-vs-Grade 3 |
2.125400E-01 |
| Grade 2-vs-Grade 4 |
3.383800E-03 |
| Grade 3-vs-Grade 4 |
5.279800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.183090E-03 |
| Normal-vs-ccB subtype |
9.522800E-01 |
| ccA subtype-vs-ccB subtype |
5.66199999999517E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.596200E-02 |
| Normal-vs-N1 |
6.410000E-01 |
| N0-vs-N1 |
8.868600E-01 |
|
|
